Etavopivat

Vendor: Abmole

Type: Molecular

SKU: M21076

$230.00 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.

Product Overview

Bioactivity
Etavopivat, an oral erythrocyte pyruvate kinase activator, is being developed for sickle cell disease and other hemoglobinopathies, previously reported in 2019.
Casnumber
2245053-57-8
Formula
C22H23N3O6S
Mw
457.50
Psmiles
C1COC2=C(O1)C=C(C=N2)S(=O)(=O)N3CC4=C(C3)CN(C4)C(=O)C(CO)C5=CC=CC=C5
Purity
>98.5%
Target synonyms
FT-4202
Etavopivat

Etavopivat

$230.00 USD